Skip to main content
. 2021 Dec 17;11(12):1380. doi: 10.3390/jpm11121380

Table 4.

Ratio of positive over total occurrences of each cluster’s categorical variables.

Cluster # 1 2 3 4
total patients 110 21 58 79
sex (male/female) 29/81 13/8 41/17 53/26
cardiovascular disease (%) 21 (19.1%) 7 (33.3%) 12 (20.7%) 28 (35.4%)
chronic kidney disease (%) 1 (0.9%) 1 (4.8%) 3 (5.2%) 3 (3.8%)
chronic obstructive pulmonary disease (%) 3 (2.7%) 1 (4.8%) 3 (5.2%) 3 (3.8%)
asthma (%) 3 (2.7%) 1 (4.8%) 1 (1.7%) 0 (0%)
diabetes (%) 13 (11.8%) 3 (14.3%) 8 (13.8%) 24 (30.4%)
arterial hypertension (%) 28 (25.5%) 4 (19.0%) 25 (43.1%) 41 (51.9%)
immunosuppression (%) 3 (2.7%) 0 (0%) 1 (1.7%) 5 (6.3%)
cancer (%) 6 (5.5%) 2 (9.5%) 2 (3.4%) 5 (6.3%)
cough (%) 19 (17.3%) 7 (33.3%) 19 (32.8%) 28 (35.4%)
fever (%) 63 (57.3%) 4 (19.0%) 49 (84.5%) 77 (97.5%)
weakness (%) 23 (20.9%) 2 (9.5%) 20 (34.5%) 38 (48.1%)
headache (%) 1 (0.9%) 0 (0%) 1 (1.7%) 3 (3.8%)
dizziness (%) 6 (5.5%) 0 (0%) 2 (3.4%) 3 (3.8%)
abdominal ache (%) 2 (1.8%) 0 (0%) 1 (1.7%) 1 (1.3%)
nausea (%) 2 (1.8%) 0 (0%) 0 (0%) 4 (5.1%)
diarrhea (%) 7 (6.4%) 0 (0%) 4 (6.9%) 6 (7.6%)
vomit (%) 4 (3.6%) 0 (0%) 3 (5.2%) 3 (3.8%)
anosmia (%) 2 (1.8%) 0 (0%) 0 (0%) 1 (1.3%)
tastelessness (%) 1 (0.9%) 0 (0%) 0 (0%) 1 (1.3%)
throat ache (%) 4 (3.6%) 0 (0%) 0 (0%) 1 (1.3%)
hospitalization ICU (%) 2 (1.8%) 5 (23.8%) 8 (13.8%) 6 (7.6%)
death (%) 1 (0.9%) 5 (23.8%) 5 (8.6%) 6 (7.6%)